期刊文献+

HIV-1对核苷类逆转录酶抑制剂产生耐药性的分子机制研究进展 被引量:2

Advances in Molecular Level Study on HIV-1 Resistance to NRTIs
下载PDF
导出
摘要 从核苷类逆转录酶抑制剂的作用机制、HIV-1对其产生耐药性的分子机制、导致耐药性产生的HIV-1逆转录酶基因突变以及HIV-1产生耐药性的分子水平检测方法等诸方面,概述近年来有关HIV-1对核苷类逆转录酶抑制剂的耐药性在分子水平上的研究进展。核苷类逆转录酶抑制剂是一类重要的抗HIV-1药物,其耐药性病毒株的产生是导致抗HIV-1治疗失败的主要原因。对HIV-1耐药性的分子机制研究必将有助于对耐药性HIV-1有效的新型抗HIV-1药物的研究与开发。 The advances in molecular level study on HIV-1 resistance to nucleoside reverse transcfiptase inhibitors (NRTIs) in recent years, including the mechanism of action of NRTIs, the molecular mechanism of HIV-1 resistance to NRTIs, NRTIs resistant reverse transcriptase mutations and the techniques for detecting HIV-1 resistance mutations, were reviewed. NRTIs are an important class of antiretroviral drugs, to which the emergence of resistant HIV-I mutants is the major cause of failure of antiretreviral therapy. The molecular level study on HIV-1 resistance is sure to promote the research and development of novel anti-HIV-1 drugs that are effective on resistant HIV-1 mutants.
作者 查佶 查树伟
出处 《药学进展》 CAS 2006年第12期535-542,共8页 Progress in Pharmaceutical Sciences
关键词 HIV 核苷类逆转录酶抑制剂 耐药性 基因突变 分子机制 HIV NRTI Drug resistance C, ene mutation Molecular mechanism
  • 相关文献

参考文献51

  • 1U.S.Food and Drug Administration.Drugs used in the treatment of HIV infection[EB/OL].(2005-10-15)[2006-02-02].http://www.fda.gov/oashi/aids/virals.html.
  • 2De Clercq E.Antiviral drugs:current state of the art[J].J Clin Virol,2001,22(1):73-89.
  • 3Arion D,Cremer N S,Parniak M A.Mechanism by which phosphonoformic acid resistance mutations restore 3'-azido-3'-deoxythymidine(AZT)[J].J Biol Chem,2000,275(13):9251-9255.
  • 4Meyer P R,Matsuura S E,Mian A M,et al.A mechanism of AZT resistance:an increase in nucleotide-dependent primer unblocking by mutant HIV-1[J].Mol Cell,1999,4 (1):35-43.
  • 5Clavel F,Hance A J.HIV Drug Resistance[J].N Engl J Med,2004,350(10):1023-1035.
  • 6Wainberg M A,Crosopoulos W C,Salomon H,et al.Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase[J].Science,1996,271(5253):1282-1285.
  • 7Boyer P L,Sarafianos S G.The M184V mutation reduces the selective excision of zidovudine 5'-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1[J].J Virol,2002,76(7):3248-3256.
  • 8Flandre P,Descamps D,Joly V,et al.A survival method to estimate the time to occurrence of mutations:an application to thymidine analogue mutations in HIV-1-infected patients[J].J Infect Dis,2004,189(5):862-870.
  • 9Masquelier B,Race E.Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT):multicenter study of patients treated with RT inhibitors[J].Antimicrob Agents Chemother,2001,45 (6):1836-1842.
  • 10Yerly S,Rakik A,De Loes S K,et al.Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse[J].J Virol,1998,72(5):3520-3523.

同被引文献27

  • 1U.S.Food and Drug Administration.Drugs used in the treatment of HIV infection.http://www.fda.gov/oashi/aids/virals.html,2006/08.
  • 2Singh IP,Bharate SB,Bhutani KK.Anti-HIV natural products.Current Science,2005,89(2):269~290.
  • 3Royer RE,Deck LM,Vander Jagt TJ,et al.Synthesis and anti-HIV activity of 1,1'-dideoxygossypol and related compounds.J Med Chem,1995,38:2427~2432.
  • 4Balci A,Sahin FI,Ekmekci A.Gossypol induced apoptosis in the human promyelocytic leukemia cell line HL 60.Tohoku J Exp Med,1999,189(1):51~57.
  • 5Mego M,Telomerase inhibitors in anticancer therapy:gossypol as a potential telomerase inhibitor.Bratisl Lek Listy,2002,103(10):378~381.
  • 6Matlin SA,Belenguer A,Stacey VE,et al.Male antifertility compounds from Tripterygium wilfordii Hook f.Contraception,1993,47(4):387~400.
  • 7Chen K,Shi Q,Kashiwada Y,et al.Anti-aids agents,6.salaspermic acid,an anti-HIV principle from Tripterygium wilfordii,and the structure-activity correlation with its related compounds.J Nat Prod,1992,55(3):340~346.
  • 8Reddy VL,Reddy SM,Ravikanth V,et al.A new bis-andrographolide ether from Andrographis paniculata nees and evaluation of anti-HIV activity.Nat Prod Res,2005,19(3):223~230.
  • 9Calabrese C,Berman SH,Babish JG,et al.A phase I trial of andrographolide in HIV positive patients and normal volunteers.Phytother Res,2000,14(5):333~338.
  • 10Basak A,Cooper S,Roberge AG,et al.Inhibition of proprotein convertases-1,-7 and furin by diterpines of andrographis paniculata and their succinoyl esters.Biochem J,1999,338(Pt1):107~113.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部